Serial 79259237
Live / Registered — Registered — international registration renewed (as of 03 Feb 2026)
What this means for you
Registered since 02 Jun 2020. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 02 Jun 2030: the §71 ten-year affidavit of use).
Record
- Serial number
- 79259237
- Registration number
- 6066278
- Mark type
- Design / logo
- Filed
- 19 Mar 2019
- Published for opposition
- 17 Mar 2020
- Registered
- 02 Jun 2020
- Next maintenance filing
- §71 ten-year affidavit of use, due by 02 Jun 2030 (grace period to 02 Dec 2030)
- Attorney of record
- Maury M. Tepper, III
Goods and services
- Class 005 — Pharmaceuticals: [ Anti-infectives; ] anti-inflammatories; [ antibacterial pharmaceuticals; antibiotics; antifungal preparations; antivirals; cardiovascular pharmaceuticals; dermatological pharmaceutical preparations, namely, pharmaceutical preparations for use in dermatology; inhaled pharmaceutical preparations for the prevention and treatment of respiratory diseases and disorders; ] pharmaceutical preparations acting on the central nervous system; [ pharmaceutical preparations and substances for the prevention and treatment of gastrointestinal diseases; ] pharmaceutical preparations for the prevention and treatment of diseases and disorders of the autoimmune system, the metabolic system, [ the endocrine system, ] the musculo-skeletal system [ and the genitourinary system ] ; [ pharmaceutical preparations for use in hematology and in tissue and organ transplantation; pharmaceutical preparations for the prevention and treatment of eye diseases and conditions; pharmaceutical preparations for the prevention and treatment of heart rhythm disorders; ] pharmaceutical preparations for the prevention and treatment of immune system related diseases and disorders [ ; pharmaceutical preparations for the prevention and treatment of kidney diseases; pharmaceutical preparations for the prevention and treatment of diabetes; pharmaceutical preparations for the prevention and treatment of hypertension; pharmaceutical preparations for the prevention and treatment of skin disorders; pharmaceutical preparations for use in dermatology; pharmaceutical preparations for use in urology; pharmaceutical preparations for use in ophthalmology; pharmaceutical preparations for the prevention and treatment of cancer and tumors; pharmaceutical preparations for the prevention and the treatment of allergies; pharmaceutical preparations for the prevention and treatment of bone diseases; pharmaceutical preparations for the prevention and treatment of respiratory diseases and asthma ]
Owner
- NOVARTIS AG, Basel, CH
- NOVARTIS AG, CH
- NOVARTIS AG, CH
Prosecution history
- 03 Oct 2026 — PARTIAL INVALIDATION OF REG EXT PROTECTION CREATED
- 03 Feb 2026 — NOTICE OF ACCEPTANCE OF SEC. 71 & 15 - E-MAILED
- 03 Feb 2026 — REGISTERED - SEC. 71 ACCEPTED & SEC. 15 ACK.
- 26 Jan 2026 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Sept 2025 — TEAS SECTION 71 & 15 RECEIVED
- 02 Jun 2025 — COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED
- 17 Oct 2020 — FINAL DECISION TRANSACTION PROCESSED BY IB
- 25 Sept 2020 — FINAL DISPOSITION NOTICE SENT TO IB
- 25 Sept 2020 — FINAL DISPOSITION PROCESSED
- 02 Sept 2020 — FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
- 02 Jun 2020 — REGISTERED-PRINCIPAL REGISTER
- 17 Mar 2020 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 17 Mar 2020 — PUBLISHED FOR OPPOSITION
- 13 Mar 2020 — NOTIFICATION PROCESSED BY IB
- 26 Feb 2020 — NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB